Fresenius Medical Care AG (ETR:FME)

Market Cap	10.59B -11.5%
Revenue (ttm)	19.48B -0.8%
Net Income	822.76M +14.6%
EPS	3.01 +23.5%
Shares Out	259.51M
PE Ratio	13.55
Forward PE	10.37
Dividend	1.49 (3.65%)
Ex-Dividend Date	May 22, 2026

Volume	672,846
Open	40.96
Previous Close	40.72
Day's Range	40.54 - 41.22
52-Week Range	34.57 - 45.90
Beta	0.79
Analysts	Hold
Price Target	40.29 (-1.27%)
Earnings Date	Nov 3, 2026

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1996
• Employees: 106,291
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: FME

Financial Performance

In 2025, Fresenius Medical Care AG's revenue was 19.63 billion, an increase of 1.51% compared to the previous year's 19.34 billion. Earnings were 978.37 million, an increase of 81.88%.

Analyst Summary

According to 16 analysts, the average rating for FME stock is "Hold." The 12-month stock price target is €40.29, which is a decrease of -1.27% from the latest price.

Price Target

€40.29

(-1.27% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error